Form 4: Gilead Sciences CFO Reports Stock Transaction
Insider Transaction (Form 4)
Andrew D Dickinson, Chief Financial Officer of Gilead Sciences, Inc., reported multiple transactions in common stock on September 10, 2026.
Summary
- Option exercise/conversion: acquired 2,797 Common Stock on September 10, 2026; holds 168,443 after (Direct).
- Tax/exercise-price withholding: disposed of 1,347 Common Stock at $144.81 ($195,059) on September 10, 2026; holds 167,096 after (Direct).
- Option exercise/conversion: disposed of 2,797 Restricted Stock Unit on September 10, 2026; holds 25,054 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew D Dickinson — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Option exercise/conversion | Common Stock | 2,797 | — | — | 168,443 |
| 2026-09-10 | Tax/exercise-price withholding | Common Stock | 1,347 | $145 | $195.1K | 167,096 |
| 2026-09-10 | Option exercise/conversion | Restricted Stock Unit | 2,797 | — | — | 25,054 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Option exercise/conversion (2,797 shares) |
| 2026-09-10 | Tax/exercise-price withholding (1,347 shares) |
| 2026-09-10 | Option exercise/conversion (2,797 shares) |
Keywords
insider transaction, Form 4, GILD, GILEAD SCIENCES, INC., neutral, Andrew D Dickinson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.